MYELODYSPLASTIC SYNDROME UNCLASSIFIABLE

This adverse event was reported 35 times

These drugs are most commonly taken by patients reporting MYELODYSPLASTIC SYNDROME UNCLASSIFIABLE:

# Drug Count
0 METHOTREXATE SODIUM 12
1 UPADACITINIB 11
2 ADALIMUMAB 10
3 INFLIXIMAB 10
4 RITUXIMAB 10
5 ABATACEPT 9
6 ADALIMUMAB-AATY 9
7 ADALIMUMAB-ADAZ 9
8 ADALIMUMAB-FKJP 9
9 ETANERCEPT 9
See all common drugs associated with MYELODYSPLASTIC SYNDROME UNCLASSIFIABLE

MYELODYSPLASTIC SYNDROME UNCLASSIFIABLE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BARICITINIB 7 0.0023
1 FLUDROCORTISONE ACETATE 1 0.0004
2 SARILUMAB 9 0.0003
3 PREDNISOLONE ACETATE 3 0.0003
4 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
5 ADALIMUMAB-FKJP 9 0.0002
6 ADALIMUMAB-AATY 9 0.0002
7 ADALIMUMAB-ADAZ 9 0.0002
8 UPADACITINIB 11 0.0001
9 DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 1 0.0001
See all drugs enriched for association with MYELODYSPLASTIC SYNDROME UNCLASSIFIABLE